GlycoMimetics Inc (NASDAQ:GLYC)

8.48
Delayed Data
As of 11:07am ET
 -0.19 / -2.19%
Today’s Change
6.02
Today|||52-Week Range
10.10
+17.78%
Year-to-Date

Today’s Trading

Previous close8.67
Today’s open8.56
Day’s range8.38 - 8.66
Volume6,651
Average volume (3 months)27,477
Market cap$164.8M
Dividend yield--
Data as of 11:07am ET, 05/26/2015

Growth & Valuation

Earnings growth (last year)-5.26%
Earnings growth (this year)+60.56%
Earnings growth (next 5 years)--
Revenue growth (last year)+276.37%
P/E ratioNM
Price/Sales8.84
Price/Book3.23

Competitors

 Today’s
change
Today’s
% change
CERUCerulean Pharma Inc+0.07+1.15%
ARGSArgos Therapeutics I...+0.06+0.75%
ANTHAnthera Pharmaceutic...-0.06-1.27%
RDHLRedhill Biopharma Lt...-0.04-0.25%
Data as of 11:36am ET, 05/26/2015

Financials

Next reporting dateJuly 31, 2015
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$15.0M
Annual profit (last year)-$11.1M
Net profit margin-74.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Rachel K. King
Chief Financial Officer &
Head-Media Relations
Brian M. Hahn
Corporate headquarters
Gaithersburg, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers